|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2008-6-19
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
To assess the effects of treatment with rituximab plus methotrexate on patient-reported outcomes in patients with active rheumatoid arthritis (RA) who experienced inadequate response to anti-tumor necrosis factor therapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0004-3591
|
|
pubmed:author |
pubmed-author:BroderM SMS,
pubmed-author:BurmesterG RGR,
pubmed-author:CravetsMM,
pubmed-author:EmeryPP,
pubmed-author:FurhtBB,
pubmed-author:JostFF,
pubmed-author:KeystoneEE,
pubmed-author:KremerJJ,
pubmed-author:LovelessJ EJE,
pubmed-author:MagriniFF,
pubmed-author:RaoR LRL,
pubmed-author:YuEE
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
59
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
785-93
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:18512710-Antibodies, Monoclonal,
pubmed-meshheading:18512710-Antibodies, Monoclonal, Murine-Derived,
pubmed-meshheading:18512710-Antirheumatic Agents,
pubmed-meshheading:18512710-Arthritis, Rheumatoid,
pubmed-meshheading:18512710-Drug Resistance,
pubmed-meshheading:18512710-Female,
pubmed-meshheading:18512710-Humans,
pubmed-meshheading:18512710-Male,
pubmed-meshheading:18512710-Middle Aged,
pubmed-meshheading:18512710-Treatment Outcome,
pubmed-meshheading:18512710-Tumor Necrosis Factor-alpha
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Improvement in patient-reported outcomes in a rituximab trial in patients with severe rheumatoid arthritis refractory to anti-tumor necrosis factor therapy.
|
|
pubmed:affiliation |
University of Toronto, Toronto, Ontario, Canada. edkeystone@mtsinai.on.ca
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial
|
